Aim: The aim of the present investigation was to evaluate clinically and radiographically the outcome of zirconia oral implants after 3 years in function.
reveal high implant survival and success rates over a long time period. Jung, Zembic, Pjetursson, Zwahlen, and Thoma (2012) reported in a systematic review a survival rate of 97.2% at 5 years and 95.2% at 10 years for commercially available titanium implants supporting single crowns (Jung et al., 2012) . The reported survival rate of implants supporting fixed dental prostheses (FDPs) was 95.6% after 5 years and 93.1% after 10 years (Jung et al., 2012) .
However, there are a number of patients demanding for metal-free solutions for implants and prosthetics. In addition, a few preclinical studies showed that a certain amount of titanium could be found in the tissues around dental implants (Addison et al., 2012; Bianco, Ducheyne, & Cuckler, 1996) . Moreover, there is some evidence that metals in the oral cavity undergo corrosion through an electrochemical redox reaction (Cadosch et al., 2010) and may provoke hypersensitivity reactions (Jacobi-Gresser, Huesker, & Schutt, 2013) or even allergic reactions (Tschernitschek, Borchers, & Geurtsen, 2005) . Even though its estimated prevalence is low (0.6%), Ti allergy can be detected in dental implant patients (Sicilia et al., 2008) .
To overcome these possible, unwelcomed reactions, zirconia implants have been investigated. They show a high biocompatibility, good physical characteristics and a tooth-like color. In vitro evaluations confirmed that zirconia is not cytotoxic and is not able to generate mutations of the cellular genome (Covacci et al., 1999) . In vivo studies reported that the osseointegration of zirconia is similar to commercially pure titanium (Kohal, Weng, Bachle, & Strub, 2004; Manzano, Herrero, & Montero, 2014) and histological investigations have shown that particularly in the early wound healing, zirconia led to an increased proliferation of osteoblasts (Hisbergues, Vendeville, & Vendeville, 2009 ). Based on the excellent mechanical properties, in particular a high flexural strength (900-1200 MPa), a high fracture toughness (7-10 MPa m ½) and a fairly high hardness (1200 HV0.1), yttria-stabilized zirconia is an appropriate biomaterial for dental implants .
Zirconia has proven its value as a preferred esthetic material in challenging gingival conditions. Jung, Sailer, Hammerle, Attin, and Schmidlin (2007) have shown that all-ceramic abutments led to less change in color in a thin gingival biotype than titanium abutments (Jung et al., 2007) .
On the other hand, zirconia can show signs of aging under certain circumstances, which has been described as low temperature degradation (Kobayashi, Kuwajima, & Masaki, 1981) . Furthermore, one study showed that zirconium can also be found around zirconia implants (Cionca, Hashim, Meyer, Michalet, & Mombelli, 2016) . Whether or not this has an influence on the long-term outcomes of endosseous ceramic implants, remains to be clarified. Although ceramic implants are presently used for several indications, a recently published systematic review (Pieralli, Kohal, Jung, Vach, & Spies, 2017 ) stated that few clinical reports on zirconia ceramic implants are available with an investigation time of 3 years and more.
Therefore, the aim of the present investigation was to evaluate clinically and radiographically the long-term safety and efficiency of zirconia oral implants for single-tooth replacement and three-unit
FDPs after 3 years in function.
| MATERIAL AND METHODS

| Study design
The study was designed as a prospective cohort investigation according to Dekkers, Egger, Altman, and Vandenbroucke (2012 
| Participants
Sixty patients in need of either exact one single-tooth replacement or exact one implant-supported three-unit fixed dental prosthesis were consecutively included. The detailed inclusion and exclusion criteria have been outlined already in a previous study (Jung et al., 2016) . In brief, the patients were only included if they were between 20 and 70 years old and in good general condition. The implant site had to be free of infection or extraction remnants and had to contain sufficient bone for the placement of an implant with a diameter of at least 4 mm and a length of 8 mm. The patients were excluded if there were any general medical findings, which did not permit the surgical procedure. Further exclusion criteria were the intake of medication that is known to interfere with the objectives of the study, pregnancy, signs of severe bruxism, a reported alcohol or drug abuse or nicotine abuse of more than 15 cigarettes per day. Also, the need for primary bone augmentation at the implantation site was an exclusion criterion;
however, a simultaneous minor bone augmentation procedure was allowed to cover any exposed rough surfaces of the implant.
| Materials
The presently investigated ceramic implant was a commercially available one-piece zirconia screw-type implant (ceramic.implant; vitaclinical, VITA Zahnfabrik, Bad Säckingen, Germany). The endosseous part is constructed in a cylindric-conical geometrical form. The available implant lengths were 8, 10, 12 and 14 mm, and the available diameters were 4.0, 4.5 and 5.5 mm.
Regarding the material composition, surface roughness and processing steps, please refer to Fischer, Schott, and Martin (2016) .
| Interventions
A late implant insertion (3 months after tooth extraction) was recommended; under optimal circumstances, a delayed implant insertion 
| Postoperative treatment
Patients were instructed not to mechanically clean the operation field but to rinse twice a day with 0.2% chlorhexidine aqueous solution. They were given antibiotic prophylaxis on the day of surgery and thereafter three times a day for 5 days (750 mg Clamoxyl ® in Zurich; 300 mg clindamycin in Freiburg) after implant placement. Analgesics (500 mg Mefenacid in Zurich; 400 mg Ibuprofen in Freiburg) were dispensed and taken according to the individual requirements. Sutures were removed 10 days after the surgical intervention.
| Prosthetic insertion and follow-ups
The During the evaluation of the radiographic outcome at the 3-year follow-up, the authors detected a calibration error (incorrect distance of implant threads) for the measurements up to the 1-year follow-up. This previously published data of the same cohort (Jung et al., 2016) were recalculated and subsequently corrected for the present publication.
| Statistical analysis
The statistical analysis was performed at the University of Freiburg,
Center for Medical Biometry and Medical Informatics, Institute for
Medical biometry and Statistics, Freiburg, Germany.
Sample size calculation has been performed as previously described in detail (Jung et al., 2016) . For the analysis of the mean marginal bone level, linear mixed models with random intercept were used to take within-subject dependencies (i.e., two implants within one patient) into account. For the clinical parameters, Wilcoxon signed-rank tests were used to compare both results of implants and corresponding teeth per time point and results between 0 and 36 months within implants and teeth, respectively.
The calculations were performed with the statistical software STATA 14.2 (StataCorp LT, College Station, TX, USA). The probability level for statistical significance was set to p < .05.
| RESULTS
| Patient demographics and baseline characteristics
Pretreatment examination was performed at 63 patients at one of the two investigation centers. Three patients had at least one violation of inclusion/exclusion criteria and were therefore excluded from the analysis. Two of these three patients received more than exactly one single-tooth replacement, and in one patient, no implant could be placed due to insufficient bone volume. At the 3-year follow-up after final prosthetic restoration, 54 patients with a total of 65 implants could be evaluated. Mean observation time was 42.73 ± 4.19 months after implantation and 36.6 ± 1.08 months after prosthetic delivery. Five patients with one implant each did not show up for different reasons (one moved away; one missed the appointment; three more patients refused further participation).
As described above, one patient with one implant dropped out short time after implant placement. 
| Analysis of the marginal bone loss (primary endpoint)
The mean marginal bone loss from implant insertion to the 3-year follow-up after the final prosthetic restoration was 0.70 mm ± 0.72 mm. The frequency distribution for mean marginal bone level changes was as follows: 13% of the implants gained marginal bone, while 56% lost less than 1 mm, 22% 1-1.5 mm, 6% 1.5-2 mm and 3% more than 2 mm of marginal bone.
None of the investigated prognostic factors (center, jaw, type of reconstruction, implant diameter and length) had a significant influence on changes in the marginal bone level, except the baseline value of mean initial insertion depth of the implants (p < .001) ( Table 4 ).
The estimator for "insertion depth" indicates that a change in in- 
| Analysis of secondary endpoint (survival rate of the implants)
During the observation time, one implant in the mandible failed 5 weeks after insertion. In addition, five implants in different patients could not be evaluated because the patients did not show up to the 3-year follow-up. Based on 55 patients with a total of 66 implants, the mean survival rate was 98.5% (95% CI: 91.8%-99.9%) after 3 years in function.
| Clinical measurements
At each visit, plaque frequency was recorded at four sites of the implants and adjacent teeth (Table 5) . At prosthetic insertion, the frequencies of plaque around implants (11.8%) and teeth (21.0%) were at the lowest level. This value increased for both groups between prosthetic insertion and the 6-month follow-up and remained on a relatively high level up to the 3-year follow-up (implants: 20.8%, teeth 41.4%). At each time point, plaque frequencies were significantly lower at implant sites compared to teeth p< .05.
At implant sites, the mean PD (Table 6 ) increased from 2.71 mm at prosthetic delivery to 3.52 mm after 3 years. Wilcoxon signed-rank test applied to the differences comparing 36 months with baseline showed significant changes in PD on patient level for implants (p < .001) but not for teeth. The mean PD at the adjacent teeth changed only from 2.53 mm to 2.54 mm during the observation period. The difference at each follow-up between implants and teeth was statistically significant (p < .0001).
The frequency of BoP (Table 7) was significantly higher during the whole observation time for implants compared to the neighboring teeth except at prosthetic insertion. The largest increase could be observed between prosthetic delivery and the 6-month follow-up for both groups. After 3 years, BOP for implants was 40.8%, which is about two times higher than for teeth (23.2%).
Mean marginal soft tissue level (Table 8) The CAL (Table 9) around the implants at prosthetic insertion was 2.76 mm and 3.14 mm at the teeth. Until the 3-year follow-up, changes per patient in CAL were not significant at implant sites (p = .523) and around teeth (p = .052). 
T A B L E 3 Marginal bone loss from baseline (implant placement) to all evaluated time points
| DISCUSSION
The present multicenter prospective cohort investigations evaluated the mean marginal bone loss, survival rate and peri-implant soft tissue conditions of 71 zirconia implants placed in 60 healthy individuals after 3 years in function. Presently, only few clinical reports on zirconia ceramic implants are available with an investigation time of 3 years and more (Pieralli et al., 2017) . Therefore, the present investigation adds to the scientific knowledge regarding these implants.
Long-term stable conditions of osseointegration around implants particularly with respect to marginal bone loss have been identified as success criteria for longevity for implants (Albrektsson, Zarb, Worthington, & Eriksson, 1986; Roos et al., 1997) . The present investigation showed a mean marginal bone loss of 0.70 mm after 3 years with the maximum loss between the interval of implantation and prosthetic delivery (0.67 mm).
Another recently published prospective clinical trial with a similar study design (Spies et al., 2015) investigated 53 immediately temporized one-piece alumina-toughened zirconia implants over an observation time of 3 years after prosthetic delivery. The authors reported a similar mean marginal bone loss over the 3 years. As in the present study, they observed the greatest amount of bone loss between implantation and prosthetic insertion (0.70 mm): No further statistically significant bone loss up to the 3-year follow-up (0.79 mm) occurred.
The finding of a pronounced MBL in the first 6 months after implant placement is in line with another study reporting on marginal bone loss over time for zirconia implants up to 4 years (Borgonovo et al., 2013) .
In a recently published systematic review (Pieralli et al., 2017) , the authors stated that no further meta-analysis for MBL of zirconia implants except for 12 months data could be performed due to the lack of long-term data. Their analysis after 12 months resulted in a MBL (Brull, van Winkelhoff, & Cune, 2014) and 0.79 mm after 3 years (Spies et al., 2015) , of 1.63 mm after 4 years (Borgonovo et al., 2013) and of 1.23 mm after 5 years (Grassi et al., 2015) . Considering the fact that after an initial remodeling, no further significant marginal bone loss could be detected, and based on MBL after 3 years in this present study, it can be concluded that marginal bone level around zirconia implants might be stable over a longer period of time.
Although in the present investigation the mean marginal bone loss amounted only to 0.70 mm, it has to be revealed that two of 65 implants had a MBL ≥ 2 mm and four implants showed a MBL between 1.5 and 2 mm. One implant of 71 failed in our investigation 5 weeks after implantation due to a loss of osseointegration. As three implants could not be evaluated at the 1-year follow-up and five at the 3-year follow-up, the survival rate was 98.6% after 1 year and 98.5% after 3 years, respectively.
T A B L E 7
Comparison of bleeding on probing frequency at implants and adjacent teeth (Δ shows the mean difference to baseline [0 month] in patients with both measurements. The p-values at the bottom refer to a Wilcoxon signed-rank test applied to the differences comparing 36 months with baseline) In a recently published systematic review (Hashim, Cionca, Courvoisier, & Mombelli, 2016) , the one-year overall survival rate of (one-and twopiece) zirconia implants was calculated with 92% (95% CI: 87%-95%).
Due to the limited observation periods of the included studies, no meta-analysis could be performed for later time points. The authors also reported a tendency toward early failure of one-piece implants with a calculated early failure rate at 77% (95% CI: 56%-90%). However, no further loss of implants could be detected up to the 3-year follow-up.
At each follow-up, soft tissue parameters were recorded of the implants and neighboring teeth. BoP was significantly more frequent after prosthetic delivery over the whole observation time for implants in comparison with teeth, although the plaque frequency was significantly lower at implant sites compared to teeth. As described in the literature, BOP is considered a clinical key measure to distinguish between disease and peri-implant health (Jepsen et al., 2015) and is always present with peri-implant disease (Zitzmann & Berglundh, 2008) .
Nevertheless, peri-implantitis is characterized by changes in the mar- Interestingly, the analysis for CAL at implant sites demonstrated no significant differences to baseline after 3 years although PD increased over time and ML remained stable. A possible reason behind this is that PD, ML and CAL have been measured individually. CAL was not calculated as the mathematically sum of PD and ML which could lead to a small discrepancy to the measured value. However, the CAL did not change significantly over the 3 years, neither for implants nor for teeth, indicating stable soft tissue conditions around the investigated implants.
The present study was designed as a prospective cohort investigation without a control group. This might be a major limitation of the study and does not allow a direct comparison within the same cohort to titanium implants. However, it allowed us to collect more data and to gain clinical experience with a rather new implant material. An affirmative factor is that the study was performed in two investigational centers, which reduces the center effect on the results.
In addition, 11 of 71 implants of the present study were placed with a simultaneous bone augmentation procedure using a xenogeneic bone substitute. This can be another limitation of the present study because bovine bone substitute shows a radiopacity similar to human bone. It is therefore often difficult to distinguish from pristine bone and could have had an influence on the radiographical measurements.
To ensure a standardized analysis of the peri-implant bone loss, we measured the highest bone-to-implant contact without differentiating between human bone and substitute.
In conclusion, the investigated one-piece zirconia implant showed a high survival rate and a low marginal bone loss after 3 years in function. Therefore, the implant can be regarded as successful for single-tooth replacement and three-unit FDPs. Nevertheless, further investigations with long-term data are still needed to confirm these positive findings.
